Skip to main content
Article
Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer
Journal of Clinical Oncology (2005)
  • S.E. Jones, University of Texas Health Science Center at San Antonio
  • J. Erban, University of Texas Health Science Center at San Antonio
  • B. Overmoyer, University of Texas Health Science Center at San Antonio
  • G.T. Budd, University of Texas Health Science Center at San Antonio
  • L. Hutchins, University of Texas Health Science Center at San Antonio
  • E. Lower, University of Texas Health Science Center at San Antonio
  • L. Laufman, University of Texas Health Science Center at San Antonio
  • S. Sundaram, University of Texas Health Science Center at San Antonio
  • W.J. Urba, University of Texas Health Science Center at San Antonio
  • K.I. Pritchard, University of Texas Health Science Center at San Antonio
  • R. Mennel, University of Texas Health Science Center at San Antonio
  • D. Richards, University of Texas Health Science Center at San Antonio
  • S. Olsen, University of Texas Health Science Center at San Antonio
  • M.L. Meyers, University of Texas Health Science Center at San Antonio
  • P.M. Ravdin, University of Texas Health Science Center at San Antonio
Publication Date
August 20, 2005
DOI
10.1200/JCO.2005.02.027
Citation Information
S.E. Jones, J. Erban, B. Overmoyer, G.T. Budd, et al.. "Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer" Journal of Clinical Oncology Vol. 23 Iss. 24 (2005) p. 5542 - 5551
Available at: http://works.bepress.com/walter-urba/259/